Search | Page 12 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant

    ... undergoing unrelated donor peripheral blood stem cell transplant . Giving chemotherapy and total-body ... Intervention:  Procedure: Allogeneic Hematopoietic Stem Cell Transplantation Undergo allogeneic ...

    Clinical Trial last updated 04/28/2016 - 1:49pm.

  2. A Phase II Trial of CD24Fc for Prevention of Acute Graft-versus-Host Disease Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplant

    ...

    Clinical Trial last updated 04/29/2016 - 11:03am.

  3. Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow

    ... are also destroyed. This is the reason for transplanting stem cells . The stem cells help to build new functioning bone marrow, red ... Mycosis fungoides, which has been shown to be amenable to allogeneic stem cell transplants. Group B: (Closed to enrollment Oct ...

    Clinical Trial last updated 04/28/2016 - 2:08pm.

  4. Stem Cell Transplants May Be An Option for Some Elderly MDS Patients

    PubMed Abstract:  Allogeneic Stem Cell Transplantations for elderly patients with Myelodysplastic Syndrome ...

    Research Review last updated 05/02/2016 - 9:33am.

  5. GVAX vs. Placebo for MDS/AML After Allo HSCT

    ... in preventing your MDS or AML from relapsing after your allogeneic stem cell transplantation. "Investigational" means that the vaccine is still ...

    Clinical Trial last updated 04/28/2016 - 12:01pm.

  6. Administration of Donor Multi TAA-Specific T Cells for AML or MDS (ADSPAM)

    ... or has not gone away after standard treatment, including an allogeneic hematopoietic stem cell transplant (HSCT). The investigators have previously used ...

    Clinical Trial last updated 04/28/2016 - 11:40am.

  7. Reduced Intensity Conditioning in Patients Aged ≤35 With Non-Malignant Disorders Undergoing UCBT, BMT, or PBSCT (RIC HSCT NMD)

    ... bone marrow transplant (BMT) or peripheral blood stem cell transplant (PBSCT) in patients with non-malignant disorders that ... and eligible to donate without previous UCB donation. 3. Allogeneic hematopoietic stem cell transplant within the previous 6 ...

    Clinical Trial last updated 06/13/2016 - 2:18pm.

  8. Azacytidine Prior to in Vivo T-cell Depleted Allo Stem Cell Transplant for Patients With Myeloid Malignancies in CR

    ... conditioning for an in vivo T-cell depleted hematopoietic stem cell transplantation for high risk myeloid malignancies in complete ... regimen of fludarabine and melphalan prior to an allogeneic hematopoietic stem cell transplantation from a related or unrelated ...

    Clinical Trial last updated 05/02/2016 - 11:10am.

  9. Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

    ... immediately Research participants must have a donor or stem cell source identified for allogeneic transplantation, either related (7/8 or 8/8 allele matched or ...

    Clinical Trial last updated 07/14/2016 - 4:08pm.

  10. CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma

    ... bone marrow , including normal blood-forming cells ( stem cells ) and cancer cells. When the healthy stem cells from a donor are ... treated with TLI and ATG reduced intensity conditioning for allogeneic transplant (any of the following AML, myelodysplastic syndrome ...

    Clinical Trial last updated 04/29/2016 - 12:36pm.